Arialys Therapeutics, a biotechnology company pioneering new precision medicines for autoimmune neuropsychiatry, announced the appointment of Peter Flynn, Ph.D., as President and Chief Executive...
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company announced the appointment of Dr. Andrew Cavey, as its Chief Executive Officer effective...
The Board of Directors of Regel Therapeutics, a gene regulation company, announced that Stephen J. Farr, PhD, begins as Chief Executive Officer (CEO).
Dr. Farr served...
Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare companies and the NHS, announces the appointment...
